OPRX OptimizeRx
- 5.150
- -0.070-1.34%
- 5.150
- 0.0000.00%
OptimizeRx News
OptimizeRx | 4: Statement of changes in beneficial ownership of securities-Officer Stelmakh Edward
OptimizeRx | 4: Statement of changes in beneficial ownership of securities-Officer Stelmakh Edward
OptimizeRx | 4: Statement of changes in beneficial ownership of securities-Officer Odence-Ford Marion
OptimizeRx | 4: Statement of changes in beneficial ownership of securities-Officer Silvestro Stephen L
OptimizeRx | 4: Statement of changes in beneficial ownership of securities-Officer Besch Doug
OptimizeRx | 10-Q: Q2 2024 Earnings Report
OptimizeRx | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB
OptimizeRx | 8-K: OptimizeRx Reports Second Quarter 2024 Financial Results
OptimizeRx | 4: Statement of changes in beneficial ownership of securities-Officer McCarthy Brian Clark
OptimizeRx | 3: Initial statement of beneficial ownership of securities-Officer McCarthy Brian Clark
OptimizeRx | S-8 POS: S-8 POS
OptimizeRx | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
OptimizeRx | 4: Statement of changes in beneficial ownership of securities-Officer FEBBO WILLIAM J
OptimizeRx | 4: Statement of changes in beneficial ownership of securities-Director Spangler Patrick D
OptimizeRx | 4: Statement of changes in beneficial ownership of securities-Director Vos Ellen O'Connor
OptimizeRx | 4: Statement of changes in beneficial ownership of securities-Director WASSON GREGORY D
OptimizeRx | 4: Statement of changes in beneficial ownership of securities-Director HALAS GUS D
OptimizeRx | 4: Statement of changes in beneficial ownership of securities-Director KLEMA CATHY
OptimizeRx | 4: Statement of changes in beneficial ownership of securities-Director Lang James Paul
OptimizeRx | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-F(10.01%),Mathew P. Arens(10.01%)
Analysis
Price Target
No Data
No Data